http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-861894-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8cbc6261d883f27c8339ffb4b4cfeaa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-267 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C10L5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C10L5-04 |
| filingDate | 1986-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-861894-L |
| titleOfInvention | Chemical compounds |
| abstract | Vitamin D analogues represented by general formula (I), in which formula X stands for hydrogen, lower alkyl, halogen or hydroxy; Y stands for hydrogen or hydroxy; R<1> and R<2>, which may be the same or different, stand for lower alkyl, optionally substitutedwith halogen or hydroxy with the proviso that R<1> and R<2> cannot both be methyl when X is other than lower alkyl, or, taken together with the carbon atom numbered 25, R<1> and R<2> can form a saturated or unsaturated C3-C9 carbocyclic ring which may optionally be substituted at any possible position(s) with lower alkyl, halogen or hydroxy; R<3> stands for hydrogen or lower alkyl; R<4> and R<5> represent either each hydrogen, or when taken together constitute a bond, with the result that a double bond connects carbon atoms numbered 22 and 23; and bioreversible derivatives thereof. The compounds of the invention have a favourable therapeutic index and are particularly useful in the treatment of human and veterinary disorders which are characterized by abnormal cell proliferation and/or cell differentiation.n[WO8700834A1] |
| priorityDate | 1985-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.